Daily FNArena News - Australia

All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest

Previous Stories

Major Setback For Navitas?

Mar 08 2017

Brokers have differing views over the extent of education provider Navitas’ latest setback.


General Insurers Face Tight Claims Budgets

Mar 07 2017

General insurers IAG and Suncorp have outlined the expected losses from February’s hail storm in Sydney. Several brokers review the impact on FY17 natural peril budgets.


Car Dealer Issue Is Soft Growth, Not ASIC

Mar 06 2017

ASIC has automotive dealer finance commissions in its sights. Brokers are not overly concerned about these changes and suspect a softer growth outlook for automotive retailing is more significant.


Orocobre Output Sputters, Likely Short Term

Mar 06 2017

Lithium producer Orocobre has encountered problems with its inventory and production guidance has been lowered. Brokers are reasonably confident the issues can be addressed.


FNArena Reporting Season Monitor

Mar 02 2017

A summary of the previous session’s corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.


Retail Challenges Step Up For RCG

Mar 01 2017

Footwear distributor/retailer RCG Corp has flagged a soft start to the second half, raising concerns about the resilience of athletic/leisure wear trends.


Growth Accelerates At NextDC

Feb 28 2017

Accelerating internet traffic bodes well for data centre operator NextDC . Brokers mull the outlook.


Super Retail Gaining Momentum

Feb 28 2017

Super Retail has taken positive action on its problematic divisions and brokers welcome renewed momentum in the business.


FNArena Reporting Season Monitor

Feb 27 2017

A summary of the previous session’s corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.


Strong New Drug Sales Lift Mayne Pharma

Feb 27 2017

Pharmaceutical distributor and manufacturer, Mayne Pharma, has bedded down its latest acquisition, while delivering strong earnings growth in the first half.



Analyse The Market From A Different Angle